Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
26.44
-1.30 (-4.69%)
At close: Oct 7, 2025, 4:00 PM EDT
26.96
+0.52 (1.97%)
After-hours: Oct 7, 2025, 6:48 PM EDT

Rapport Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22
1,219649--
Enterprise Value
971330--
Last Close Price
26.4417.74--
PB Ratio
3.662.12--
P/TBV Ratio
4.632.12--
Debt / Equity Ratio
0.050.010.050.54
Quick Ratio
21.9334.8216.7518.74
Current Ratio
22.7535.3417.1418.80
Return on Equity (ROE)
-29.42%-35.09%-43.36%-
Return on Assets (ROA)
-20.14%-22.07%-24.18%-
Return on Capital (ROIC)
-20.71%-22.86%-25.52%-
Earnings Yield
-7.24%-12.07%--
FCF Yield
-6.30%-10.36%--
Buyback Yield / Dilution
-784.65%-1277.25%-93.74%-
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q